CHAPTER 4: POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Glucose Monitoring Kits
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Infectious Diseases Testing Kits
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Pregnancy And Fertility Testing Kits
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Hematology Testing Kits
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Cardiometabolic Monitoring Kits
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Urinalysis Testing Kits
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Cholesterol Test Strips
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Drugs Abuse Testing Kits
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
5.0 Others
5.0.1 Key market trends, growth factors and opportunities
5.0.2 Market size and forecast, by region
5.0.3 Market analysis by country
CHAPTER 7: POINT OF CARE DIAGNOSTICS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Mode Of Prescription
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Mode Of Prescription
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Mode Of Prescription
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Mode Of Prescription
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Mode Of Prescription
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Mode Of Prescription
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Mode Of Prescription
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Mode Of Prescription
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Mode Of Prescription
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Mode Of Prescription
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Mode Of Prescription
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Mode Of Prescription
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Mode Of Prescription
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Mode Of Prescription
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Mode Of Prescription
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Mode Of Prescription
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Mode Of Prescription
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Mode Of Prescription
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Mode Of Prescription
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Mode Of Prescription
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Mode Of Prescription
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Mode Of Prescription
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Mode Of Prescription
7.5.5.4.3 Market size and forecast, by End User
LIST OF TABLES
Table 1. Global Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 2. Point of Care Diagnostics Market Revenue, for Glucose Monitoring Kits, by Region, 2020-2030, ($Million)
Table 3. Point of Care Diagnostics Market Glucose Monitoring Kits by Country, 2020-2030, ($Million)
Table 4. Point of Care Diagnostics Market Revenue, for Infectious Diseases Testing Kits, by Region, 2020-2030, ($Million)
Table 5. Point of Care Diagnostics Market Infectious Diseases Testing Kits by Country, 2020-2030, ($Million)
Table 6. Point of Care Diagnostics Market Revenue, for Pregnancy and Fertility Testing Kits, by Region, 2020-2030, ($Million)
Table 7. Point of Care Diagnostics Market Pregnancy and Fertility Testing Kits by Country, 2020-2030, ($Million)
Table 8. Point of Care Diagnostics Market Revenue, for Hematology Testing Kits, by Region, 2020-2030, ($Million)
Table 9. Point of Care Diagnostics Market Hematology Testing Kits by Country, 2020-2030, ($Million)
Table 10. Point of Care Diagnostics Market Revenue, for Cardiometabolic Monitoring Kits, by Region, 2020-2030, ($Million)
Table 11. Point of Care Diagnostics Market Cardiometabolic Monitoring Kits by Country, 2020-2030, ($Million)
Table 12. Point of Care Diagnostics Market Revenue, for Urinalysis Testing Kits, by Region, 2020-2030, ($Million)
Table 13. Point of Care Diagnostics Market Urinalysis Testing Kits by Country, 2020-2030, ($Million)
Table 14. Point of Care Diagnostics Market Revenue, for Cholesterol Test Strips, by Region, 2020-2030, ($Million)
Table 15. Point of Care Diagnostics Market Cholesterol Test Strips by Country, 2020-2030, ($Million)
Table 16. Point of Care Diagnostics Market Revenue, for Drugs Abuse Testing Kits, by Region, 2020-2030, ($Million)
Table 17. Point of Care Diagnostics Market Drugs Abuse Testing Kits by Country, 2020-2030, ($Million)
Table 18. Point of Care Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 19. Point of Care Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 20. Global Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 21. Point of Care Diagnostics Market Revenue, for Prescription Based Devices, by Region, 2020-2030, ($Million)
Table 22. Point of Care Diagnostics Market Prescription Based Devices by Country, 2020-2030, ($Million)
Table 23. Point of Care Diagnostics Market Revenue, for OTC Based Devices, by Region, 2020-2030, ($Million)
Table 24. Point of Care Diagnostics Market OTC Based Devices by Country, 2020-2030, ($Million)
Table 25. Global Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 26. Point of Care Diagnostics Market Revenue, for Professional Diagnostic Centers, by Region, 2020-2030, ($Million)
Table 27. Point of Care Diagnostics Market Professional Diagnostic Centers by Country, 2020-2030, ($Million)
Table 28. Point of Care Diagnostics Market Revenue, for Research Laboratories, by Region, 2020-2030, ($Million)
Table 29. Point of Care Diagnostics Market Research Laboratories by Country, 2020-2030, ($Million)
Table 30. Point of Care Diagnostics Market Revenue, for Home Care, by Region, 2020-2030, ($Million)
Table 31. Point of Care Diagnostics Market Home Care by Country, 2020-2030, ($Million)
Table 32. Point of Care Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 33. Point of Care Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 34. Point of Care Diagnostics Market, by Region, 2020-2030, ($Million)
Table 35. North America Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 36. North America Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 37. North America Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 38. North America Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 39. U.S. Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 40. U.S. Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 41. U.S. Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 42. Canada Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 43. Canada Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 44. Canada Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 45. Mexico Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 46. Mexico Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 47. Mexico Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 48. Europe Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 49. Europe Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 50. Europe Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 51. Europe Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 52. Germany Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 53. Germany Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 54. Germany Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 55. France Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 56. France Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 57. France Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 58. U.K. Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 59. U.K. Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 60. U.K. Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 61. Italy Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 62. Italy Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 63. Italy Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 64. Spain Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 65. Spain Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 66. Spain Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 67. Rest of Europe Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 68. Rest of Europe Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 69. Rest of Europe Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 70. Asia-Pacific Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 71. Asia-Pacific Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 72. Asia-Pacific Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 73. Asia-Pacific Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 74. Japan Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 75. Japan Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 76. Japan Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 77. China Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 78. China Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 79. China Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 80. Australia Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 81. Australia Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 82. Australia Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 83. India Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 84. India Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 85. India Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 86. South Korea Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 87. South Korea Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 88. South Korea Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 89. Rest of Asia-Pacific Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 90. Rest of Asia-Pacific Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 91. Rest of Asia-Pacific Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 92. LAMEA Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 93. LAMEA Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 94. LAMEA Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 95. LAMEA Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 96. Brazil Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 97. Brazil Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 98. Brazil Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 99. Saudi Arabia Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 100. Saudi Arabia Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 101. Saudi Arabia Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 102. South Africa Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 103. South Africa Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 104. South Africa Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 105. Rest of LAMEA Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 106. Rest of LAMEA Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 107. Rest of LAMEA Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 108. Johnson and Johnson: Company Snapshot
Table 109. Johnson and Johnson: Operating Segments
Table 110. Johnson and Johnson: Product Portfolio
Table 111. Johnson and Johnson: Net Sales
Table 112. Johnson and Johnson: Key Stratergies
Table 113. Sysmex Corporation: Company Snapshot
Table 114. Sysmex Corporation: Operating Segments
Table 115. Sysmex Corporation: Product Portfolio
Table 116. Sysmex Corporation: Net Sales
Table 117. Sysmex Corporation: Key Stratergies
Table 118. Nova Biomedical: Company Snapshot
Table 119. Nova Biomedical: Operating Segments
Table 120. Nova Biomedical: Product Portfolio
Table 121. Nova Biomedical: Net Sales
Table 122. Nova Biomedical: Key Stratergies
Table 123. Danaher Corporation: Company Snapshot
Table 124. Danaher Corporation: Operating Segments
Table 125. Danaher Corporation: Product Portfolio
Table 126. Danaher Corporation: Net Sales
Table 127. Danaher Corporation: Key Stratergies
Table 128. Becton Dickinson and Company: Company Snapshot
Table 129. Becton Dickinson and Company: Operating Segments
Table 130. Becton Dickinson and Company: Product Portfolio
Table 131. Becton Dickinson and Company: Net Sales
Table 132. Becton Dickinson and Company: Key Stratergies
Table 133. Biomrieux Sa: Company Snapshot
Table 134. Biomrieux Sa: Operating Segments
Table 135. Biomrieux Sa: Product Portfolio
Table 136. Biomrieux Sa: Net Sales
Table 137. Biomrieux Sa: Key Stratergies
Table 138. Abbott Laboratories: Company Snapshot
Table 139. Abbott Laboratories: Operating Segments
Table 140. Abbott Laboratories: Product Portfolio
Table 141. Abbott Laboratories: Net Sales
Table 142. Abbott Laboratories: Key Stratergies
Table 143. Siemens Ag: Company Snapshot
Table 144. Siemens Ag: Operating Segments
Table 145. Siemens Ag: Product Portfolio
Table 146. Siemens Ag: Net Sales
Table 147. Siemens Ag: Key Stratergies
Table 148. Hoffmann La Roche Ltd: Company Snapshot
Table 149. Hoffmann La Roche Ltd: Operating Segments
Table 150. Hoffmann La Roche Ltd: Product Portfolio
Table 151. Hoffmann La Roche Ltd: Net Sales
Table 152. Hoffmann La Roche Ltd: Key Stratergies
Table 153. Sinocare Inc.: Company Snapshot
Table 154. Sinocare Inc.: Operating Segments
Table 155. Sinocare Inc.: Product Portfolio
Table 156. Sinocare Inc.: Net Sales
Table 157. Sinocare Inc.: Key Stratergies
LIST OF FIGURES
Figure 1. Point of Care Diagnostics Market Segmentation
Figure 2. Point of Care Diagnostics Market, 2020-2030
Figure 3. Point of Care Diagnostics Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Point of Care Diagnostics Market:Drivers, Restraints and Opportunities
Figure 11. Point of Care Diagnostics Market, by Product, 2020 (%)
Figure 12. Comparative Share Analysis of Glucose Monitoring Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Infectious Diseases Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Pregnancy and Fertility Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 15. Comparative Share Analysis of Hematology Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Cardiometabolic Monitoring Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Urinalysis Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Cholesterol Test Strips Point of Care Diagnostics Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Drugs Abuse Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 20. Comparative Share Analysis of Others Point of Care Diagnostics Market, 2020-2030 (%)
Figure 21. Point of Care Diagnostics Market, by Mode of Prescription, 2020 (%)
Figure 22. Comparative Share Analysis of Prescription Based Devices Point of Care Diagnostics Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of OTC Based Devices Point of Care Diagnostics Market, 2020-2030 (%)
Figure 24. Point of Care Diagnostics Market, by End-user, 2020 (%)
Figure 25. Comparative Share Analysis of Professional Diagnostic Centers Point of Care Diagnostics Market, 2020-2030 (%)
Figure 26. Comparative Share Analysis of Research Laboratories Point of Care Diagnostics Market, 2020-2030 (%)
Figure 27. Comparative Share Analysis of Home Care Point of Care Diagnostics Market, 2020-2030 (%)
Figure 28. Comparative Share Analysis of Others Point of Care Diagnostics Market, 2020-2030 (%)
Figure 29. Point of Care Diagnostics Market by Region, 2020
Figure 30. U.S. Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 31. Canada Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 32. Mexico Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 33. Germany Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 34. France Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 35. U.K. Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 36. Italy Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 37. Spain Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 38. Rest of Europe Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 39. Japan Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 40. China Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 41. Australia Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 42. India Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 43. South Korea Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 44. Rest of Asia-Pacific Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 45. Brazil Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 46. Saudi Arabia Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 47. South Africa Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 48. Rest of LAMEA Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 49. Top Winning Strategies, by Year
Figure 50. Top Winning Strategies, by Development
Figure 51. Top Winning Strategies, by Company
Figure 52. Product Mapping of Top 10 Players
Figure 53. Competitive Dashboard
Figure 54. Competitive Heatmap of Top 10 Key Players
Figure 55. Johnson and Johnson.: Net Sales, ($Million)
Figure 56. Sysmex Corporation.: Net Sales, ($Million)
Figure 57. Nova Biomedical.: Net Sales, ($Million)
Figure 58. Danaher Corporation.: Net Sales, ($Million)
Figure 59. Becton Dickinson and Company.: Net Sales, ($Million)
Figure 60. Biomrieux SA.: Net Sales, ($Million)
Figure 61. Abbott Laboratories.: Net Sales, ($Million)
Figure 62. Siemens AG.: Net Sales, ($Million)
Figure 63. Hoffmann La Roche Ltd.: Net Sales, ($Million)
Figure 64. Sinocare Inc. Net Sales, ($Million)